| Nov 13 |
Zentalis Pharmaceuticals names Julie Eastland as CEO
|
| Nov 13 |
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
|
| Oct 22 |
Undervalued Opportunities: US Penny Stocks To Watch In October 2024
|
| Oct 18 |
State Street Corp's Strategic Reduction in Zentalis Pharmaceuticals Holdings
|
| Oct 15 |
Several Insiders Invested In Zentalis Pharmaceuticals Flagging Positive News
|
| Oct 7 |
FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc
|
| Sep 19 |
Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
|
| Sep 17 |
FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor
|
| Sep 17 |
Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies
|
| Sep 16 |
Zentalis stock rises after FDA lifts partial clinical hold on azenosertib studies
|
